Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,549.50 GBX | +1.74% |
|
+2.48% | +15.08% |
08:07pm | US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults | RE |
07:33pm | US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults | RE |
MarketScreener Strategies
Filters
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions